✦ LIBER ✦

High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: The university of Chicago experience

✍ Scribed by Keith L. Shulman; Walter M. Stadler; Nicholas J. Vogelzang

Book ID: 119488061
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 506 KB
Volume: 47
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(99)80414-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose Interleukin-2 Therapy for Meta

High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma: A Contemporary Experience

✍ Hanzly, Michael; Aboumohamed, Ahmed; Yarlagadda, Naveen; Creighton, Terrance; Di 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 444 KB

The treatment of metastatic renal cell c

The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2

✍ Gore, M.E.; Galligioni, E.; Keen, C.W.; Sorio, R.; Loriaux, E.M.; Grobben, H.C.; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 621 KB

The application of high-dose interleukin

The application of high-dose interleukin-2 for metastatic renal cell carcinoma

✍ David F. McDermott 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 192 KB

A single-centre experience with continuo

A single-centre experience with continuous intravenous infusion of recombinant interleukin-2 ± lak cells in metastatic renal cell cancer

✍ Besana, C; Borri, A; Bucci, E; Tresoldi, M; Di Lucca, G; Schönheit, A; Citterio, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

Continuous infusion of recombinant inter

Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma

✍ Palmer, Peter A.; Vinke, Jan; Evers, Pauline; Pourreau, Catherine; Oskam, Ralph; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 876 KB